K+S Reports Final FREP Findings - Quick Facts

K+S Group (SDFG) said the German Financial Reporting Enforcement Panel e.V. or FREP - DPR, has issued its final examination findings in the procedure for the examination of the consolidated financial statements of the Group as of December 31, 2019, and the abbreviated consolidated financial statements as of June 30, 2020. K+S stated that the final findings do not result in any adjustment requirements for the valuations of the Potash and Magnesium Products cash-generating unit in the respective financial statements.

K+S noted that it has been requested by the DPR to indicate whether it agrees or disagrees with the findings by December 9, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Teva Pharmaceuticals USA, Inc. has recalled one lot of platelet-reducing drug Anagrelide in the form of capsules due to dissolution test failure detected during routine stability testing, the U.S. Food and Drug Administration, or FDA, said in a statement. The U.S. Food and Drug Administration said it has taken steps to make available millions of cans of additional infant and specialty formula to U.S. consumers in the coming months. Under the agency's recent increased flexibilities, British nutrition products maker Kendal Nutricare will send about 2 million cans of infant formula under the Kendamil brand initially to U.S. beginning in June. Video streaming giant Netflix Inc. announced the availability of a variety of mobile games. Players can download the games directly from the Netflix mobile app. The new games include Dragon Up (East Side Games), Moonlighter (11 Bit Studios), Townsmen - A Kingdom Rebuilt (HandyGames), and Exploding Kittens - The Game (Exploding Kittens Digital).
Follow RTT